CRSP crisprtx.com: Sof marja

crisprtx.com (CRSP) - korporativ logo

Birinchi gen terapiyasi tasdiqlari daromadli bo'lish uchun asos yaratadi, garchi pul oqimi hamkorliklar tufayli cheklangan bo'lsa-da. GURU.Markets interfeysi ushbu grafikni namoyish etadi, unda CRISPR Therapeutics AG (CRSP) kompaniyasining tijorat foyda marjasi eng so'nggi ma'lumotlarni aks ettirgan holda -1812.10 ga yetadi. Biznes samaradorligi biomateriallar uchun murakkab kriogen logistika bilan ta'minlanadi. Shu bilan birga, CRISPR Therapeutics AG (CRSP) o'z laboratoriyalarida yashil standartlar va toza energiyani joriy qilmoqda.

crisprtx.com (CRSP) - Sof marja 04.07.2022dan 20.11.2026gacha

CRISPR Therapeutics Corp - tahliliy kesimlar va asosiy koʻrsatkichlar (CRSP)

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:CRISPR Therapeutics Inc - CRSP
CRISPR Therapeutics Inc tayyor mahsulotlari

Konservativ investor uchun sof marja dinamikasi samaradorlik filtri vazifasini o'tab, barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin har bir dollar daromadning qancha qismi sof foyda ekanligini o'lchaydi. CRISPR Therapeutics AG (CRSP) holatida ushbu ko'rsatkich biolaboratoriyalarning etik ESG optimallashtiruvi xarajatlari va yuqori texnologiyali gen terapiyasining uzoq muddatda real erkin pul oqimini yaratish qobiliyati o'rtasidagi muvozanatni aks ettiradi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|Kompaniya sotuv marjasi GeneDx|Sof marja Ultragenyx RARE|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX